SAT0321 MKP-1 as a Protective Factor and Novel Drug Target in Scleroderma: MKP-1 Deficient Mice Develop More Severe Dermal Fibrosis in a Widely Used Experimental Model of Scleroderma
doi 10.1136/annrheumdis-2017-eular.4816
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism